Nigel Davies

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Top Venues

Molecular pharmaceutics

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Tejedor, Maria Wågberg, Cláudia Correia, Karin Åvall, Mikko Hölttä, Leif Hultin, Michael Lerche, Nigel Davies, Nils Bergenhem, Arjan Snijder, Tom Marlow, Pierre Dönnes, Regina Fritsche-Danielson, Jane Synnergren, Karin Jennbacken, Kenny Hansson
The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation. Cells 13 (5) (2024)
Sandra Tejedor, Maria Wågberg, Cláudia Correia, Karin Åvall, Mikko Hölttä, Leif Hultin, Michael Lerche, Nigel Davies, Nils Bergenhem, Arjan Snijder, Tom Marlow, Pierre Dönnes, Regina Fritsche-Danielson, Jane Synnergren, Karin Jennbacken, Kenny Hansson
The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation. Cells 13 (5) (2024)
Sandra Tejedor, Maria Wågberg, Cláudia Correia, Karin Åvall, Mikko Hölttä, Leif Hultin, Michael Lerche, Nigel Davies, Nils Bergenhem, Arjan Snijder, Tom Marlow, Pierre Dönnes, Regina Fritsche-Danielson, Jane Synnergren, Karin Jennbacken, Kenny Hansson
The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation. Cells 13 (5) (2024)
Asmaa McGowan, Peter Gennemark, Marceline Akieh-Pirkanniemi, Linda Wirman, Nigel Davies, Marie Elebring, Anna Tivesten, Marie Strimfors, Mikko Hölttä, Magnus Söderberg, Veronica Berntsson, Daniela Balas, Mika Koskinen, Lasse Leino, Susanna Abrahmsén-Alami
Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration. Molecular pharmaceutics (2023)
Asmaa McGowan, Peter Gennemark, Marceline Akieh-Pirkanniemi, Linda Wirman, Nigel Davies, Marie Elebring, Anna Tivesten, Marie Strimfors, Mikko Hölttä, Magnus Söderberg, Veronica Berntsson, Daniela Balas, Mika Koskinen, Lasse Leino, Susanna Abrahmsén-Alami
Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration. Molecular pharmaceutics 21 (1) (2023)
Asmaa McGowan, Peter Gennemark, Marceline Akieh-Pirkanniemi, Linda Wirman, Nigel Davies, Marie Elebring, Anna Tivesten, Marie Strimfors, Mikko Hölttä, Magnus Söderberg, Veronica Berntsson, Daniela Balas, Mika Koskinen, Lasse Leino, Susanna Abrahmsén-Alami
Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration. Molecular pharmaceutics 21 (1) (2023)
Prosper Emeh, Katarina Breitholtz, Staffan Berg, Charlotta Vedin, Maria Englund, Teresia Uggla, Malin Antonsson, Filipe Nunes, Constanze Hilgendorf, Christel A S Bergstrom, Nigel Davies
Experiences and Translatability of In Vitro and In Vivo Models to Evaluate Caprate as a Permeation Enhancer. Molecular pharmaceutics (2023)
Peter Gennemark, Katrin Walter, Niclas Clemmensen, Dinko Rekić, Catarina A M Nilsson, Jane Knöchel, Mikko Hölttä, Linda Wernevik, Birgitta Rosengren, Dorota Kakol-Palm, Yanfeng Wang, Rosie Z Yu, Richard S Geary, Stan J Riney, Brett P Monia, Rikard Isaksson, Rasmus Jansson-Löfmark, Cristina S J Rocha, Daniel Lindén, Eva Hurt-Camejo, Rosanne Crooke, Lloyd Tillman, Tina Rydén-Bergsten, Björn C L Carlsson, Ulf Andersson, Marie Elebring, Anna Tivesten, Nigel Davies
An oral antisense oligonucleotide for PCSK9 inhibition. Science translational medicine 13 (593) (2021)